Relmacabtagene Autoleucel in Hematologic Malignancies

Clinical trial NCT06142188 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06142188
Sponsor: Shanghai Ming Ju Biotechnology Co., Ltd.
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Lymphoma, B-Cell Large B-cell Lymphoma Follicular Lymphoma

Start date: 2023-12-28
Primary completion: 2038-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.